Cargando…

Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours

OBJECTIVE: Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) encompass a diverse group of neoplasms that vary in their secretory products and in their location within the gastrointestinal tract. Their prevalence in the USA is increasing among all adult age groups. AIM: To identify the possibl...

Descripción completa

Detalles Bibliográficos
Autores principales: Rico, Karen, Duan, Suzann, Pandey, Ritu L, Chen, Yuliang, Chakrabarti, Jayati T, Starr, Julie, Zavros, Yana, Else, Tobias, Katona, Bryson W, Metz, David C, Merchant, Juanita L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576490/
https://www.ncbi.nlm.nih.gov/pubmed/34750164
http://dx.doi.org/10.1136/bmjgast-2021-000765
_version_ 1784595887164489728
author Rico, Karen
Duan, Suzann
Pandey, Ritu L
Chen, Yuliang
Chakrabarti, Jayati T
Starr, Julie
Zavros, Yana
Else, Tobias
Katona, Bryson W
Metz, David C
Merchant, Juanita L
author_facet Rico, Karen
Duan, Suzann
Pandey, Ritu L
Chen, Yuliang
Chakrabarti, Jayati T
Starr, Julie
Zavros, Yana
Else, Tobias
Katona, Bryson W
Metz, David C
Merchant, Juanita L
author_sort Rico, Karen
collection PubMed
description OBJECTIVE: Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) encompass a diverse group of neoplasms that vary in their secretory products and in their location within the gastrointestinal tract. Their prevalence in the USA is increasing among all adult age groups. AIM: To identify the possible derivation of GEP-NETs using genome-wide analyses to distinguish small intestinal neuroendocrine tumours, specifically duodenal gastrinomas (DGASTs), from pancreatic neuroendocrine tumours. DESIGN: Whole exome sequencing and RNA-sequencing were performed on surgically resected GEP-NETs (discovery cohort). RNA transcript profiles available in the Gene Expression Omnibus were analysed using R integrated software (validation cohort). Digital spatial profiling (DSP) was used to analyse paraffin-embedded GEP-NETs. Human duodenal organoids were treated with 5 or 10 ng/mL of tumor necrosis factor alpha (TNFα) prior to qPCR and western blot analysis of neuroendocrine cell specification genes. RESULTS: Both the discovery and validation cohorts of small intestinal neuroendocrine tumours induced expression of mesenchymal and calcium signalling pathways coincident with a decrease in intestine-specific genes. In particular, calcium-related, smooth muscle and cytoskeletal genes increased in DGASTs, but did not correlate with MEN1 mutation status. Interleukin 17 (IL-17) and tumor necrosis factor alpha (TNFα) signalling pathways were elevated in the DGAST RNA-sequencing. However, DSP analysis confirmed a paucity of immune cells in DGASTs compared with the adjacent tumour-associated Brunner’s glands. Immunofluorescent analysis showed production of these proinflammatory cytokines and phosphorylated signal transducer and activator of transcription 3 (pSTAT3) by the tumours and stroma. Human duodenal organoids treated with TNFα induced neuroendocrine tumour genes, SYP, CHGA and NKX6.3. CONCLUSIONS: Stromal–epithelial interactions induce proinflammatory cytokines that promote Brunner’s gland reprogramming.
format Online
Article
Text
id pubmed-8576490
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-85764902021-11-19 Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours Rico, Karen Duan, Suzann Pandey, Ritu L Chen, Yuliang Chakrabarti, Jayati T Starr, Julie Zavros, Yana Else, Tobias Katona, Bryson W Metz, David C Merchant, Juanita L BMJ Open Gastroenterol Neuroendocrine Tumours OBJECTIVE: Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) encompass a diverse group of neoplasms that vary in their secretory products and in their location within the gastrointestinal tract. Their prevalence in the USA is increasing among all adult age groups. AIM: To identify the possible derivation of GEP-NETs using genome-wide analyses to distinguish small intestinal neuroendocrine tumours, specifically duodenal gastrinomas (DGASTs), from pancreatic neuroendocrine tumours. DESIGN: Whole exome sequencing and RNA-sequencing were performed on surgically resected GEP-NETs (discovery cohort). RNA transcript profiles available in the Gene Expression Omnibus were analysed using R integrated software (validation cohort). Digital spatial profiling (DSP) was used to analyse paraffin-embedded GEP-NETs. Human duodenal organoids were treated with 5 or 10 ng/mL of tumor necrosis factor alpha (TNFα) prior to qPCR and western blot analysis of neuroendocrine cell specification genes. RESULTS: Both the discovery and validation cohorts of small intestinal neuroendocrine tumours induced expression of mesenchymal and calcium signalling pathways coincident with a decrease in intestine-specific genes. In particular, calcium-related, smooth muscle and cytoskeletal genes increased in DGASTs, but did not correlate with MEN1 mutation status. Interleukin 17 (IL-17) and tumor necrosis factor alpha (TNFα) signalling pathways were elevated in the DGAST RNA-sequencing. However, DSP analysis confirmed a paucity of immune cells in DGASTs compared with the adjacent tumour-associated Brunner’s glands. Immunofluorescent analysis showed production of these proinflammatory cytokines and phosphorylated signal transducer and activator of transcription 3 (pSTAT3) by the tumours and stroma. Human duodenal organoids treated with TNFα induced neuroendocrine tumour genes, SYP, CHGA and NKX6.3. CONCLUSIONS: Stromal–epithelial interactions induce proinflammatory cytokines that promote Brunner’s gland reprogramming. BMJ Publishing Group 2021-11-08 /pmc/articles/PMC8576490/ /pubmed/34750164 http://dx.doi.org/10.1136/bmjgast-2021-000765 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Neuroendocrine Tumours
Rico, Karen
Duan, Suzann
Pandey, Ritu L
Chen, Yuliang
Chakrabarti, Jayati T
Starr, Julie
Zavros, Yana
Else, Tobias
Katona, Bryson W
Metz, David C
Merchant, Juanita L
Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours
title Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours
title_full Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours
title_fullStr Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours
title_full_unstemmed Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours
title_short Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours
title_sort genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours
topic Neuroendocrine Tumours
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576490/
https://www.ncbi.nlm.nih.gov/pubmed/34750164
http://dx.doi.org/10.1136/bmjgast-2021-000765
work_keys_str_mv AT ricokaren genomeanalysisidentifiesdifferencesinthetranscriptionaltargetsofduodenalversuspancreaticneuroendocrinetumours
AT duansuzann genomeanalysisidentifiesdifferencesinthetranscriptionaltargetsofduodenalversuspancreaticneuroendocrinetumours
AT pandeyritul genomeanalysisidentifiesdifferencesinthetranscriptionaltargetsofduodenalversuspancreaticneuroendocrinetumours
AT chenyuliang genomeanalysisidentifiesdifferencesinthetranscriptionaltargetsofduodenalversuspancreaticneuroendocrinetumours
AT chakrabartijayatit genomeanalysisidentifiesdifferencesinthetranscriptionaltargetsofduodenalversuspancreaticneuroendocrinetumours
AT starrjulie genomeanalysisidentifiesdifferencesinthetranscriptionaltargetsofduodenalversuspancreaticneuroendocrinetumours
AT zavrosyana genomeanalysisidentifiesdifferencesinthetranscriptionaltargetsofduodenalversuspancreaticneuroendocrinetumours
AT elsetobias genomeanalysisidentifiesdifferencesinthetranscriptionaltargetsofduodenalversuspancreaticneuroendocrinetumours
AT katonabrysonw genomeanalysisidentifiesdifferencesinthetranscriptionaltargetsofduodenalversuspancreaticneuroendocrinetumours
AT metzdavidc genomeanalysisidentifiesdifferencesinthetranscriptionaltargetsofduodenalversuspancreaticneuroendocrinetumours
AT merchantjuanital genomeanalysisidentifiesdifferencesinthetranscriptionaltargetsofduodenalversuspancreaticneuroendocrinetumours